胡盛寿，男，1957年生，中共党员，中国工程院院士，心血管外科学专家，博士生导师。现任国家心血管病中心主任，中国医学科学院阜外医院院长，心血管疾病国家重点实验室主任、国家心血管疾病临床医学研究中心主任。“973”首席科学家，“国家杰出青年科学基金”获得者，教育部“创新团队”学科带头人，法国医学科学院外籍院士，英国牛津大学客座教授。

复杂性先天性心脏病外科治疗临床及基础研究；细胞治疗和组织工程学技术在心血管疾病中应用研究；人工心脏和心室辅助的研究；同种及异种心脏移植免疫学原理研究；免疫激活促心肌再生研究。

全国十大赌博官网

1. Chen L#, Hua K#, Zhang N, Wang J, Meng J, Hu Z, Gao H, Li F, Chen Y, Ren J, Liu L, Zhou Q, Gu J, Song J*, Zhang X*, Hu S*. Multifaceted Spatial and Functional Zonation of Cardiac Cells in Adult Human Heart. Circulation. 2022 Jan 25;145(4):315-318.

2. Tian M#, Wang X, Sun H, Feng W, Song Y, Lu F, Wang L, Wang Y, Xu B, Wang H, Liu S, Liu Z, Chen Y, Miao Q, Su P, Yang Y, Guo S, Lu B, Sun Z, Liu K, Zhang C, Wu Y, Xu H, Zhao W, Han C, Zhou X, Wang E, Huo X, Hu S*. No-Touch Versus Conventional Vein Harvesting Techniques at 12 Months After Coronary Artery Bypass Grafting Surgery: Multicenter Randomized, Controlled Trial. Circulation. 2021 Oct 5;144(14):1120-1129.

3. Rao M#, Wang X#, Guo G#, Wang L, Chen S, Yin P, Chen K, Chen L, Zhang Z, Chen X, Hu X*, Hu S*, Song J*. Resolving the intertwining of inflammation and fibrosis in human heart failure at single-cell level. Basic Res Cardiol. 2021 Oct 3;116(1):55.

4. Li X#, Krumholz HM#, Yip W#, Cheng KK, De Maeseneer J, Meng Q, Mossialos E, Li C, Lu J, Su M, Zhang Q, Xu DR, Li L, Normand ST, Peto R, Li J, Wang Z, Yan H, Gao R, Chunharas S, Gao X, Guerra R, Ji H, Ke Y, Pan Z, Wu X, Xiao S, Xie X, Zhang Y, Zhu J, Zhu S, Hu S*. Quality of primary health care in China: challenges and recommendations. Lancet. 2020 Jun 6;395(10239):1802-1812.

5. Li Y#, Feng J, Song S, Li H, Yang H, Zhou B, Li Y, Yue Z, Lian H, Liu L, Hu S*, Nie Y*. gp130 Controls Cardiomyocyte Proliferation and Heart Regeneration. Circulation. 2020 Sep 8;142(10):967-982.

6. Chu Q#, Jiang H, Zhang L, Zhu D, Yin Q, Zhang H, Zhou B, Zhou W, Yue Z, Lian H, Liu L, Nie Y*, Hu S*. CACCT: An Automated Tool of Detecting Complicated Cardiac Malformations in Mouse Models. Adv Sci (Weinh). 2020 Feb 20;7(8):1903592. doi: 10.1002/advs.201903592. PMID: 32328433; PMCID: PMC7175298.

7. Song JP#, Chen L#, Chen X, Ren J, Zhang NN, Tirasawasdichai T, Hu ZL, Hua W, Hu YR, Tang HR, Chen HV*, Hu SS*. Elevated plasma β-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy. Sci Transl Med. 2020 Feb 12;12(530):eaay8329.

8. Chen L#, Song J#, Chen X#, Chen K, Ren J, Zhang N, Rao M, Hu Z, Zhang Y, Gu M, Zhao H, Tang H, Yang Z, Hu S*. A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression. Eur Heart J. 2019 Jun 1;40(21):1690-1703.

9. Li X#, Lu J#, Hu S, Cheng KK, De Maeseneer J, Meng Q, Mossialos E, Xu DR, Yip W, Zhang H, Krumholz HM, Jiang L, Hu S*. The primary health-care system in China. Lancet. 2017 Dec 9;390(10112):2584-2594.

10. Xu B#, Tu S, Qiao S, Qu X, Chen Y, Yang J, Guo L, Sun Z, Li Z, Tian F, Fang W, Chen J, Li W, Guan C, Holm NR, Wijns W, Hu S*. Diagnostic Accuracy of Angiography-Based Quantitative Flow Ratio Measurements for Online Assessment of Coronary Stenosis. J Am Coll Cardiol. 2017 Dec 26;70(25):3077-3087.